quinic acid has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, J; He, H; Miller, DD; Pagadala, J; Steinle, JJ; Toutounchian, JJ; Weir, RL; Yates, CR | 1 |
1 other study(ies) available for quinic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
The quinic acid derivative KZ-41 prevents glucose-induced caspase-3 activation in retinal endothelial cells through an IGF-1 receptor dependent mechanism.
Topics: Caspase 3; Cells, Cultured; Diabetic Retinopathy; Endothelial Cells; Enzyme Activation; Glucose; Humans; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinic Acid; Receptor, IGF Type 1; Retina; Signal Transduction | 2017 |